Skip to main content

Research Repository

Advanced Search

Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis

Duckworth, Carrie A.; Guimond, Scott E.; Sindrewicz, Paulina; Hughes, Ashley J.; French, Neil S.; Lian, Lu-Yun; Yates, Edwin A.; Pritchard, D. Mark; Rhodes, Jonathan M.; Turnbull, Jeremy E.; Yu, Lu-Gang

Authors

Carrie A. Duckworth

Paulina Sindrewicz

Ashley J. Hughes

Neil S. French

Lu-Yun Lian

Edwin A. Yates

D. Mark Pritchard

Jonathan M. Rhodes

Lu-Gang Yu



Citation

Duckworth, C. A., Guimond, S. E., Sindrewicz, P., Hughes, A. J., French, N. S., Lian, L., …Yu, L. (2015). Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis. Oncotarget, 6(27), 23671-23687. https://doi.org/10.18632/oncotarget.4409

Journal Article Type Article
Online Publication Date Jun 23, 2015
Publication Date Sep 15, 2015
Deposit Date Jun 5, 2023
Journal Oncotarget
Print ISSN 1949-2553
Publisher Impact Journals
Peer Reviewed Peer Reviewed
Volume 6
Issue 27
Pages 23671-23687
DOI https://doi.org/10.18632/oncotarget.4409
Keywords Oncology